BRYAN BURKE: Open Payments
NPI 1609186089 · JOHNSON CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$711 in 29 payments from 9 companies in 2025. Trend: 2023 $707 · 2024 $294 · 2025 $711
Food & beverage: $711
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $253 |
| Novo Nordisk Inc | 5 | $138 |
| Lilly USA, LLC | 3 | $84 |
| Exact Sciences Corporation | 2 | $52 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| PFIZER INC. | 3 | $46 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Amgen Inc. | 1 | $24 |
Products named: BREZTRI, Ozempic, MOUNJARO, VOQUEZNA, FARXIGA, AIRSUPRA, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit.
Industry payments across NY — which companies pay providers there.
